InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Leong Justin, Président, Asie et Amérique Latine. Director active across 1 company, notably RESMED INC. Cumulatively, 11 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €10.9m. Activity tracked since 19 August 2021. The latest transaction was disclosed on 20 November 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Leong Justin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
1,848 股0ReMed Common StockSEC:0000943819-25-000179:0
5,462 股0ReMed Common StockSEC:0000943819-25-000041:0
6,160 股@ US$243.0875.8% 占其流量ReMed Common StockSEC:0001127602-24-027960:0
8,259 股0ReMed Common StockSEC:0001127602-24-022299:0
48,000 股@ US$217.07438.5% 占其流量ReMed Common StockSEC:0001127602-24-021754:0
15,000 股@ US$57.763.4% 占其流量ReMed Common StockSEC:0001127602-22-026349:0
9,162 股@ US$254.810.0074% mcap15.9% 占其流量ReMed Common StockSEC:0001127602-22-000624:0
1,339 股@ US$254.812.1% 占其流量ReMed Common StockSEC:0001127602-21-029802:0
9,162 股@ US$254.810.0074% mcap15.9% 占其流量ReMed Common StockSEC:0001127602-21-029581:0
9,162 股@ US$254.8114.5% 占其流量ReMed Common StockSEC:0001127602-21-029616:0
2,631 股0ReMed Common StockSEC:0001127602-21-024090:0
11 条申报中的 11 条
About Leong Justin
Leong Justin is Président, Asie et Amérique Latine, and Chief Product Officer at RESMED INC (XNAS). He has 11 filings in total, and across the 11 sampled filings between 2021-08-20 and 2025-11-24, sales total 10945005 EUR and Attribution is the most frequent transaction nature.
